Australia's CSL, Ansell join global medical response to Ebola

SYDNEY, Oct 17 (Reuters) - Australian biotech firm CSL Ltd , the world's second-biggest blood products maker, said on Friday it's working on a plasma product to treat Ebola following a request from the Bill & Melinda Gates Foundation, part of a growing commercial response to the deadly outbreak.